Inhibitor Therapeutics, Inc. (INTI)

Latest Insider Confidence Score

2025Q4

50.0
Bullish

Company insider confidence (by quarter)

2003Q3 2025Q4

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Mayne Pharma Group Ltd 10% Owner 204,083,227 Jan 19, 2021
Mayne Pharma International Pty Ltd 10% Owner 204,083,227 Jan 19, 2021
Mayne Pharma Ventures Pty Ltd 10% Owner 204,083,227 Jan 19, 2021
Odonnell Francis E Jr Chair 85,627,069 Dec 22, 2022
HedgePath, LLC — 79,627,069 Jul 12, 2017

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Apr 1, 2025 Apr 10, 2025 Vasisht Niraj Director Neutral 52.5 - 0.00% ✗ -
Apr 1, 2025 Apr 7, 2025 Yanez Michelle Director Neutral 85.0 +50,000 5.91% ✗ -
Apr 1, 2025 Apr 7, 2025 SEARS SAMUEL P JR Director Neutral 82.5 +50,000 4.07% ✗ -
Apr 1, 2025 Apr 7, 2025 OSMAN RONALD E Director Neutral 60.0 +50,000 0.21% ✗ -
Apr 1, 2025 Apr 7, 2025 Jerman Michael Allen Director Neutral 90.0 +50,000 164.41% ✗ -
Dec 2, 2024 Feb 19, 2025 MCNULTY JAMES A CFO Neutral 90.0 +1,000,000 105.69% ✗ -
Dec 2, 2024 Feb 19, 2025 Yanez Michelle Director Neutral 90.0 +250,000 27.89% ✗ -
Apr 1, 2024 May 16, 2024 Yanez Michelle Director Neutral 85.0 +50,000 5.91% ✗ -
Mar 16, 2024 May 16, 2024 MCNULTY JAMES A CFO Neutral 52.5 - 0.00% ✗ -
Apr 1, 2024 May 16, 2024 SEARS SAMUEL P JR Director Neutral 82.5 +50,000 4.63% ✗ -
Apr 1, 2024 May 16, 2024 OSMAN RONALD E Director Neutral 60.0 +50,000 0.21% ✗ -
Apr 1, 2024 May 16, 2024 Jerman Michael Allen Director Neutral 90.0 +50,000 164.41% ✗ -
Aug 11, 2023 Aug 29, 2023 OSMAN RONALD E Director Neutral 55.0 +25,000 0.11% ✗ -
Aug 29, 2023 Ronald E Osman Irrevocable Trust III 10% Owner Neutral 52.5 - 0.00% ✗ -
May 22, 2023 TPB 2012 LLC 10% Owner Neutral 52.5 - 0.00% ✗ -
May 5, 2023 May 17, 2023 MCNULTY JAMES A Officer Neutral 27.5 -59,127,877 -68.61% ✗ -
May 17, 2023 Black Robe Capital LLC 10% Owner Neutral 52.5 - 0.00% ✗ -
May 5, 2023 May 17, 2023 Yanez Michelle Director Neutral 90.0 +796,271 18088.85% ✗ -
Dec 22, 2022 SEARS SAMUEL P JR Director Neutral 52.5 - 0.00% ✗ -
Dec 22, 2022 Vasisht Niraj Director Neutral 52.5 - 0.00% ✗ -
Dec 22, 2022 Yanez Michelle Director Neutral 52.5 - 0.00% ✗ -
Dec 22, 2022 ODONNELL FRANCIS E JR Officer Neutral 52.5 - 0.00% ✗ -
Dec 22, 2022 MCNULTY JAMES A Officer Neutral 52.5 - 0.00% ✗ -
Jan 15, 2021 Jan 19, 2021 Mayne Pharma Ventures Pty Ltd 10% Owner Neutral 77.5 +2,240,488 1.11% ✗ -
Dec 22, 2020 Dec 28, 2020 Hasara Garrison J. CFO Neutral 52.5 - 0.00% ✗ -
Dec 22, 2020 Dec 28, 2020 Watson W. Mark Director Neutral 52.5 - 0.00% ✗ -
Dec 22, 2020 Dec 28, 2020 Ono Richard Dana Director Neutral 52.5 - 0.00% ✗ -
Dec 22, 2020 Dec 28, 2020 Peattie Debra Director Neutral 52.5 - 0.00% ✗ -
Dec 22, 2020 Dec 28, 2020 VIRCA NICHOLAS J CEO Neutral 52.5 - 0.00% ✗ -
Dec 22, 2020 Dec 28, 2020 Martin Robert Daniel Director Neutral 52.5 - 0.00% ✗ -
Sep 17, 2020 Sep 21, 2020 VIRCA NICHOLAS J CEO Neutral 52.5 - 0.00% ✗ -
Sep 17, 2020 Sep 21, 2020 Hasara Garrison J. CFO Neutral 52.5 - 0.00% ✗ -
Jul 15, 2020 Jul 20, 2020 Mayne Pharma Ventures Pty Ltd 10% Owner Neutral 77.5 +3,189,688 1.61% ✗ -
Mar 20, 2020 Mar 24, 2020 Ono Richard Dana Director Neutral 52.5 - 0.00% ✗ -
Mar 20, 2020 Mar 24, 2020 Peattie Debra Director Neutral 52.5 - 0.00% ✗ -
Mar 20, 2020 Mar 24, 2020 Martin Robert Daniel Director Neutral 52.5 - 0.00% ✗ -
Mar 20, 2020 Mar 24, 2020 Watson W. Mark Director Neutral 52.5 - 0.00% ✗ -
Dec 12, 2019 Feb 10, 2020 Watson W. Mark Director Buy 47.5 +500 0.05% ✗ $31
Dec 12, 2019 Dec 16, 2019 Peattie Debra Director Neutral 52.5 - 0.00% ✗ -
Dec 2, 2019 Dec 2, 2019 Hasara Garrison J. CFO Buy 60.0 +13,500 0.34% ✗ $945
Nov 1, 2019 Peattie Debra Director Neutral 52.5 - 0.00% ✗ -
Jun 3, 2019 Jun 10, 2019 Watson W. Mark Director Neutral 52.5 - 0.00% ✗ -
Feb 3, 2019 Feb 5, 2019 Ono Richard Dana Director Neutral 52.5 - 0.00% ✗ -
Feb 3, 2019 Feb 5, 2019 Martin Robert Daniel Director Neutral 52.5 - 0.00% ✗ -
Feb 3, 2019 Feb 5, 2019 Watson W. Mark Director Neutral 52.5 - 0.00% ✗ -
Feb 3, 2019 Feb 5, 2019 MAGRAB E. BRENDAN Director Neutral 52.5 - 0.00% ✗ -
Jan 15, 2019 Jan 24, 2019 Mayne Pharma Ventures Pty Ltd 10% Owner Neutral 55.0 +362,121 0.18% ✗ -
Dec 20, 2018 Dec 26, 2018 Martin Robert Daniel Director Neutral 90.0 +60,000 107.14% ✗ -
Dec 20, 2018 Dec 26, 2018 MAGRAB E. BRENDAN Director Neutral 90.0 +65,000 100.00% ✗ -
Jul 15, 2018 Dec 19, 2018 Mayne Pharma Ventures Pty Ltd 10% Owner Neutral 55.0 +184,798 0.09% ✗ -
Aug 30, 2018 Aug 31, 2018 Hasara Garrison J. CFO Sell 26.3 -100,000 -2.46% ✗ $27K
Jul 5, 2018 Jul 6, 2018 Mayne Pharma Ventures Pty Ltd 10% Owner Neutral 52.5 - 0.00% ✗ -
Mar 13, 2018 Mar 15, 2018 Martin Robert Daniel Director Neutral 52.5 - 0.00% ✗ -
Mar 13, 2018 Mar 15, 2018 MAGRAB E. BRENDAN Chair Neutral 52.5 - 0.00% ✗ -
Mar 13, 2018 Mar 15, 2018 Ono Richard Dana Director Neutral 52.5 - 0.00% ✗ -
Mar 13, 2018 Mar 15, 2018 Watson W. Mark Director Neutral 52.5 - 0.00% ✗ -
Mar 13, 2018 Mar 15, 2018 Hasara Garrison J. CFO Neutral 52.5 - 0.00% ✗ -
Mar 13, 2018 Mar 15, 2018 VIRCA NICHOLAS J CEO Neutral 52.5 - 0.00% ✗ -
Dec 19, 2017 Feb 12, 2018 Cross Stefan Director Sell 15.0 -600,000 -100.00% ✗ $97.6B
Dec 19, 2017 Feb 12, 2018 Mayne Pharma Ventures Pty Ltd 10% Owner Buy 72.5 +600,000 0.30% ✗ $97.6B
Jan 10, 2018 Jan 11, 2018 Mayne Pharma Ventures Pty Ltd 10% Owner Neutral 52.5 - 0.00% ✗ -
May 4, 2017 Jul 19, 2017 Martin Robert Daniel Director Neutral 52.5 - 0.00% ✗ -
May 4, 2017 Jul 19, 2017 MAGRAB E. BRENDAN Chair Neutral 52.5 - 0.00% ✗ -
Jun 30, 2017 Jul 12, 2017 HedgePath, LLC 10% Owner Neutral 27.5 -2,500,000 -3.04% ✗ -
Mar 8, 2017 Mar 10, 2017 Watson W. Mark Director Sell 22.5 -356,400 -23.23% ✗ $121.2K
Mar 8, 2017 Mar 10, 2017 Hasara Garrison J. CFO Sell 20.0 -2,940,956 -32.57% ✗ $999.9K
Mar 8, 2017 Mar 10, 2017 VIRCA NICHOLAS J CEO Sell 17.5 -6,314,219 -41.98% ✗ $2.1M
Mar 8, 2017 Mar 10, 2017 Cross Stefan Director Neutral 52.5 - 0.00% ✗ -
Mar 8, 2017 Mar 10, 2017 Ono Richard Dana Director Sell 22.5 -297,000 -22.96% ✗ $101K
Dec 6, 2016 Martin Robert Daniel Director Neutral 52.5 - 0.00% ✗ -
Nov 30, 2016 MAGRAB E. BRENDAN Chair Neutral 52.5 - 0.00% ✗ -
Nov 15, 2016 Nov 15, 2016 Mayne Pharma Ventures Pty Ltd 10% Owner Neutral 52.5 - 0.00% ✗ -
Nov 4, 2016 Nov 7, 2016 Mayne Pharma Ventures Pty Ltd 10% Owner Neutral 52.5 - 0.00% ✗ -
Jul 1, 2016 Jul 6, 2016 Watson W. Mark Director Neutral 52.5 - 0.00% ✗ -
Jul 1, 2016 Jul 6, 2016 SEARS SAMUEL P JR Director Neutral 52.5 - 0.00% ✗ -
Jul 1, 2016 Jul 6, 2016 Ono Richard Dana Director Neutral 52.5 - 0.00% ✗ -
Jun 15, 2016 Jun 20, 2016 HedgePath, LLC 10% Owner Neutral 27.5 -2,560,000 -3.02% ✗ -
Jun 15, 2016 Jun 20, 2016 ODONNELL FRANCIS E JR Chair Neutral 90.0 +2,560,000 18.29% ✗ -
Jun 15, 2016 Jun 17, 2016 ODONNELL FRANCIS E JR Chair Neutral 27.5 -2,560,000 -18.29% ✗ -
Jun 6, 2016 Jun 8, 2016 ODONNELL FRANCIS E JR Chair Neutral 27.5 -6,000,000 -30.00% ✗ -
May 25, 2016 May 27, 2016 Mayne Pharma Group Ltd 10% Owner Neutral 90.0 +27,885,000 23.01% ✗ -
Sep 10, 2015 Sep 14, 2015 HedgePath, LLC 10% Owner Neutral 27.5 -20,000,000 -19.10% ✗ -
Sep 10, 2015 Sep 14, 2015 ODONNELL FRANCIS E JR Chair Neutral 90.0 +20,000,000 100.00% ✗ -
Aug 14, 2015 Aug 18, 2015 Cross Stefan Director Neutral 52.5 - 0.00% ✗ -
Aug 14, 2015 Aug 18, 2015 Ono Richard Dana Director Neutral 52.5 - 0.00% ✗ -
Aug 14, 2015 Aug 18, 2015 SEARS SAMUEL P JR Director Neutral 52.5 - 0.00% ✗ -
Aug 14, 2015 Aug 18, 2015 Watson W. Mark Director Neutral 52.5 - 0.00% ✗ -
May 15, 2015 May 19, 2015 Mayne Pharma Group Ltd 10% Owner Neutral 90.0 +33,333,333 37.95% ✗ -
Jul 18, 2014 Feb 6, 2015 Watson W. Mark Director Neutral 52.5 - 0.00% ✗ -
Jul 18, 2014 Feb 6, 2015 Ono Richard Dana Director Neutral 52.5 - 0.00% ✗ -
Jul 18, 2014 Feb 6, 2015 SEARS SAMUEL P JR Director Neutral 52.5 - 0.00% ✗ -
Aug 6, 2014 Feb 6, 2015 Hasara Garrison J. CFO Neutral 52.5 - 0.00% ✗ -
Jul 18, 2014 Feb 6, 2015 VIRCA NICHOLAS J CEO Neutral 52.5 - 0.00% ✗ -
Jul 18, 2014 Feb 6, 2015 Cross Stefan Director Neutral 52.5 - 0.00% ✗ -
Sep 8, 2014 Sep 9, 2014 Watson W. Mark Director Buy 90.0 +10,000 100.00% ✗ $1.3K
Jun 24, 2014 Jul 9, 2014 HedgePath, LLC 10% Owner Neutral 90.0 +22,530,227 890.44% ✗ -
Jun 24, 2014 Jul 9, 2014 ODONNELL FRANCIS E JR Chair Buy 97.5 +7,232,203 890.44% ✗ $481.5K
Jul 7, 2014 Ono Richard Dana Director Neutral 52.5 - 0.00% ✗ -
Jul 7, 2014 Watson W. Mark Director Neutral 52.5 - 0.00% ✗ -
Jun 26, 2014 Mayne Pharma Group Ltd 10% Owner Neutral 52.5 - 0.00% ✗ -